在头部和部癌症中,阿雷卡坚果诱导的癌症发生的miRNA剖析
Hung-Han Huang1,2, Joseph T Chang3,4, Guo-Rung You2
1Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Cancers
|November 9, 2024
概括
这项研究确定了一种独特的microRNA (miRNA) 签名,与阿雷卡坚果诱导的头癌 (HNC) 有关. 这种签名为早期检测和改善HNC患者治疗策略提供了潜力.
科学领域:
- 分子瘤学分子瘤学
- 癌症基因组学 癌症基因组学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 微RNAs (miRNAs) 涉及癌症,但它们在头癌 (HNC) 和Areca坚果癌症发生中的作用尚不清楚.
- 阿雷卡坚果在东南亚是一个重要的致癌物,其作用机制尚不清楚.
研究的目的:
- 系统地识别与阿雷卡坚果诱导的HNC相关的miRNA配置文件.
- 为了定义一个诊断和预后miRNA签名的阿雷卡坚果相关的HNC.
主要方法:
- 在阿雷卡坚果处理的HNC细胞中进行miRNA微阵列分析.
- 癌症基因组图集的生物信息分析 头部和部状细胞癌 (TCGA-HNSC) 数据集.
- 集成微阵列和TCGA数据来定义一个miRNA签名.
- 多次MIR分析以确定目标基因和途径.
主要成果:
- 在阿雷卡坚果处理的HNC细胞中鉴定了292个失调的miRNA (136个上调,156个下调).
- 在TCGA-HNSC数据集中发现了692个与HNC发育相关的miRNA (449个过度表达,243个表达不足).
- 定义了一个84-miRNA特征 (39致瘤,45抑制瘤) 在Areca坚果癌症发生中至关重要.
- 鉴定了740个基因,这些基因由抑制瘤的小RNAs调节,影响关键的癌症途径 (p53,PI3K-AKT,MAPK,Ras).
- 验证了miR-499a-5p作为一个关键的调节剂,可以缓解阿雷卡坚果诱导的癌症进展.
结论:
- 已识别的miRNA签名阐明了阿雷卡坚果诱导的致癌的分子机制.
- 这种签名为临床应用提供了一个有前途的工具,用于风险评估,诊断和预后的阿雷卡坚果相关的恶性瘤.
相关概念视频
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


